Advances and Future Perspectives of HER2 Mutations in Non-Small Lung Cancer (NSCLC), Especially in China

Advances and Future Perspectives of HER2 Mutations in Non-Small Lung Cancer (NSCLC), Especially in China

HER2-mutated non-small lung cancer (NSCLC) in China represents a substantial patient population characterized by an unfavorable prognosis. However, at present, the main clinical treatment options are relatively limited. HER2 mutations in Chinese NSCLC (2019-2024) demonstrated 3.8%-5.6% prevalence vi...

Full description

Saved in:
Bibliographic Details
Main Authors: Chang Liu MS, Tao Li MD, Xiaoran Cui MD, Yahui Lv MS, Min Liu MS, Xin Zhou MS, Fan Yang MS, Yi Dong MS, Ruixin Li MS, Fan Zhang MD, Tong Zhang MD, Yi Hu MD
Format: Article
Language:English
Published: SAGE Publishing 2025-05-01
Series:Cancer Control
Online Access:https://doi.org/10.1177/10732748251347572
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1177/10732748251347572

Similar Items